Wordt geladen...
Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
Cost-effectiveness analyses (CEAs) alongside randomised controlled trials (RCTs) are increasingly designed to collect resource use and preference-based health status data for the purpose of healthcare technology assessment. However, because of the way these measures are collected, they are prone to...
Bewaard in:
| Gepubliceerd in: | Pharmacoecon Open |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer International Publishing
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691848/ https://ncbi.nlm.nih.gov/pubmed/29442336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41669-017-0015-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|